Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...
2 Weight Loss Stocks That Are Screaming Buys in December
With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...
Seven reasons why Americans pay more for health care than any other nation
Americans pay more for health care but don't get better results. Why? The blame goes well beyond insurance companies.
Can Ozempic cause sudden vision loss? A study uncovers the link
A new study confirms a link between Novo Nordisk's Ozempic and an increased risk of NAION, a rare, irreversible form of ...
verywellhealth on MSN23h
Zepbound Helps People Shed More Weight Than Wegovy, According to Eli Lilly Trial
Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...
Hosted on MSN23h
Novo says Catalent deal regulatory closing conditions fulfilled
Novo Nordisk (NVO) announced that as of today, all regulatory closing conditions relating to the review of its pending acquisition of Catalent ...
Pharmaceutical Technology4h
Risk adjusted net present value: What is the current valuation of Novo Nordisk’s Amycretin?
The drug candidate is developed based on SNAC technology. Novo Nordisk, a subsidiary of Novo Holdings AS, is a healthcare company with focus on discovering, developing, and manufacturing biological ...